<?xml version="1.0" encoding="UTF-8"?>
<svg height="698.627" width="532.107" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="102.103" x="76.272,81.588,85.127,89.558,92.802,95.902,99.003,102.103" y="21.089000000000055" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">Cancers </text>
  <text x="104.096,108.081,112.066,116.051" y="21.089000000000055" svg_rhmargin="120.036" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:7.97px;font-style:NORMAL;font-weight:BOLD;">2019</text>
  <text svg_rhmargin="122.029" x="120.036,122.029" y="21.089000000000055" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="124.021,128.006" y="21.089000000000055" svg_rhmargin="131.991" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="131.991,133.984,135.976,139.961,143.94600000000003,491.809,495.794,499.779,501.772,506.123,508.777,510.77,514.755" y="21.089000000000055" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, 47 25 of 27</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="55.95799999999997" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">31. </text>
  <text x="98.05,106.702,111.275,116.79,120.667,122.95400000000001,125.204,133.856,136.142,141.593,143.879,146.166,148.425,156.034,160.607,165.18,169.057,171.344,173.594,180.709,182.996,189.105,191.391,193.678,195.937,201.525,205.906,210.478,213.46,216.441,220.53,222.817,225.066,232.044,234.331,239.919,242.205,244.49200000000002,246.75,253.866,256.527,261.585,265.966,268.627,274.215,278.788,281.075,283.324,288.126,290.412,299.064,301.35,303.637,305.896,311.484,315.865,321.032,323.693,329.016,333.397,335.68399999999997,337.933,343.521,345.808,351.396,353.682,355.969,358.228,363.816,366.477,371.992,374.279,376.528,382.629,384.915,387.202,389.46,395.561,400.883,405.456,410.45,412.73699999999997,414.986,420.099,422.385,424.67199999999997,426.921,433.561,438.134,440.795,445.789,449.667,451.95399999999995,454.212,462.864,465.15,467.43699999999995,469.696,472.741,478.256,483.579,487.951,490.238,492.496,498.981,501.267,508.876,511.16299999999995,513.413" y="55.95799999999997" svg_rhmargin="519.019" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Maus, M.V.; Haas, A.R.; Beatty, G.L.; Albelda, S.M.; Levine, B.L.; Liu, X.; Zhao, Y.; Kalos, M.; June, C.H. T</text>
  <text svg_rhmargin="403.758" x="98.05,102.027,106.318,108.924,111.531,115.32900000000001,117.577,121.868,126.49,131.873,135.25,139.541,143.339,147.137,149.743,154.957,159.93699999999998,162.185,166.162,171.376,173.982,181.892,186.182,189.72,192.327,196.304,198.552,203.031,208.244,211.164,213.771,218.751,223.042,228.255,230.504,233.881,238.171,242.148,246.439,251.822,254.742,259.633,263.171,266.969,269.218,273.195,277.673,282.886,285.135,289.112,293.591,298.992,302.79,307.08000000000004,309.329,313.808,319.021,323.5,328.883,334.096,339.077,341.683,346.162,350.784,353.391,357.189,359.437,362.044,367.257,369.505,374.718,380.12,388.029,392.508,397.721,401.519,403.758" y="68.87" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cells expressing chimeric antigen receptors can cause anaphylaxis in humans. </text>
  <text svg_rhmargin="487.916" x="406.556,412.531,416.508,421.488,425.134,428.618,432.102,434.351,437.334,444.303,451.271,456.252,461.232,465.209,467.699,469.938,472.734,478.708,482.193,485.677,487.916" y="68.87" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Cancer Immunol. Res. </text>
  <text x="490.721,495.204,499.687,504.171" y="68.87" svg_rhmargin="508.654" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2013</text>
  <text svg_rhmargin="510.892" x="508.653,510.892" y="68.87" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="513.143" y="68.87" svg_rhmargin="517.622" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">1</text>
  <text x="517.622" y="68.87" svg_rhmargin="519.861" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="98.05,102.533,107.016,111.5,115.983,120.466,122.708,125.487,128.473,134.83,138.211,143.106,146.908,150.71,156.699,160.994,163.98,166.96599999999998,169.207,172.193,177.609,183.016,187.974,196.456,200.751,206.23" y="81.78200000000004" svg_rhmargin="209.216" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">26–31. [CrossRef] [PubMed]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="94.69299999999998" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">32. </text>
  <text x="98.05,103.656,108.979,111.641,115.518,118.5,121.161,125.542,128.524,133.846,141.474,146.047,148.708,151.69,156.07,158.357,163.003,167.265,169.551,176.036,178.322,180.609,186.471,193.449,196.111,198.772,204.095,208.668,216.743,219.03,223.676,230.755,233.041,238.629,240.915,243.202,249.055,256.033,261.548,265.929,269.807,272.788,275.075,279.73,285.839,288.126,295.204,297.491,299.77799999999996,305.631,311.74,316.734,319.715,325.038,332.665,337.046,339.708,342.369,344.656,349.311,356.389,358.676,365.654,367.94,370.227,376.08,381.604,384.266,386.927,389.588,394.161,396.823,399.10999999999996,403.764,412.416,414.703,416.98999999999995,422.842,428.43,433.945,437.558,440.539,442.82599999999996,447.472,454.551,456.837,459.883,462.169,464.45599999999996,470.318,475.906,480.991,485.564,488.545,491.527,495.908,498.195,502.84,509.955,512.242,515.287,517.574" y="94.69299999999998" svg_rhmargin="519.86" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Thistlethwaite, F.C.; Gilham, D.E.; Guest, R.D.; Rothwell, D.G.; Pillai, M.; Burt, D.J.; Byatte, A.J.;</text>
  <text x="98.05,104.429,106.986,110.457,113.014,115.571,118.128,122.926,127.891,132.284,134.481,136.564,143.866,146.063,148.26,150.395,155.913,160.306,162.863,165.42,169.629,171.826,173.918,176.844,179.04,187.002,189.198,191.395,193.53,198.144,203.258,207.651,211.122,218.881,223.275,225.472,227.554,232.167,234.364,240.743,242.94,245.137,247.272,251.481,254.346,256.428,260.822,263.379,265.576,268.308,273.695,278.809,283.01800000000003,285.1,289.002,291.559,294.116,299.23,301.787,305.689,310.082,312.639,314.722,318.931,321.699,327.015,330.916,335.31,339.211,344.09700000000004,346.179,350.977,353.90299999999996,355.986,361.302,364.773,368.499,371.363,374.289,379.175,383.384,388.498,392.707,396.178,400.571,403.436,405.993,410.791,415.905,417.987,421.889,426.282,429.595,433.496,436.053,441.168,445.965,450.174,457.933,462.793,466.263,471.149,475.947,481.061,483.618,487.519,489.602,493.995,499.109,501.974,504.531,509.417,513.626" y="107.60500000000002" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Kirillova, N.; Valle, J.W.; Sharma, S.K.; et al. The clinical efﬁcacy of ﬁrst-generation carcinoembryonic antigen</text>
  <text x="97.755,100.744,107.107,112.591,119.574,125.938,132.92,141.411,145.899,148.888,151.876,155.682,161.076,165.375,169.36,171.972,177.402,181.387,183.64,190.004,196.987,202.982,205.235,210.73700000000002,212.99,216.975,221.274,223.886,226.498,230.303,232.565,235.177,238.982,241.235,243.847,246.459,254.384,256.996,259.922,264.221,269.705,271.958,276.921,281.911,284.164,289.559,294.459,299.36,302.90500000000003,305.158,310.552,314.851,318.396,322.202,324.814,328.619,331.545,335.844,341.068,345.053,349.352,351.605,356.093,361.316,366.79999999999995,369.062,371.988,375.533,380.021,385.245,389.05,391.662,395.961,401.185,404.111,406.364,411.758,415.142,419.441,422.43,426.415,431.315,436.539,442.023,444.635,447.561,450.173,455.073,460.297,462.909,468.132,473.123,476.111,481.595,485.894,491.289,495.588,500.812,506.295,510.595,515.818" y="120.51599999999996" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">(CEACAM5)-speciﬁc CAR T cells is limited by poor persistence and transient pre-conditioning-dependent</text>
  <text svg_rhmargin="174.937" x="98.05,101.43,105.725,109.527,114.916,117.525,121.067,125.55,128.473,133.369,136.91,141.895,144.137,147.06,151.956,156.583,159.192,163.173,165.782,168.705,172.695,174.93699999999998" y="133.428" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">respiratory toxicity. </text>
  <text svg_rhmargin="290.845" x="177.716,183.697,187.678,192.663,196.312,199.8,203.288,205.53,208.516,215.491,222.467,227.453,232.438,236.419,238.912,241.154,243.933,246.919,253.895,260.87,265.856,270.841,274.822,277.808,282.291,285.779,288.603,290.845" y="133.428" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Cancer Immunol. Immunother. </text>
  <text x="293.622,298.105,302.588,307.072" y="133.428" svg_rhmargin="311.555" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2017</text>
  <text svg_rhmargin="313.797" x="311.555,313.797" y="133.428" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="316.038,320.521" y="133.428" svg_rhmargin="325.004" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">66</text>
  <text x="325.005,327.247,329.488,333.971,338.455,342.938,347.421,351.904,356.388,360.871,365.354,369.837,372.079,374.858,377.844,384.201,387.582,392.477,396.279,400.081,406.07,410.365,413.351,416.337,418.578,421.564,426.98,432.387,437.345,445.827,450.122,455.601" y="133.428" svg_rhmargin="458.587" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 1425–1436. [CrossRef] [PubMed]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="146.34000000000003" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">33. </text>
  <text x="98.05,103.638,108.211,116.287,120.667,124.28,128.158,130.445,133.746,140.23,142.517,150.126,152.412,154.699,158.531,163.332,165.994,170.374,173.036,175.176,178.221,182.602,185.547,187.834,191.135,195.937,198.223,200.51000000000002,204.342,209.509,214.082,219.405,222.706,227.508,230.489,234.87,239.251,244.574,249.631,254.012,257.46,262.545,266.926,272.249,274.536,277.837,282.638,284.925,287.212,291.043,296.211,300.783,306.106,309.399,314.987,317.648,322.221,326.794,331.879,336.964,341.345,344.299,346.58599999999996,349.887,354.249,356.536,358.823,362.654,367.822,372.395,377.71799999999996,381.019,387.659,391.271,393.933,402.008,407.505,411.886,417.209,419.496,422.797,428.385,430.671,432.95799999999997,436.78,443.759,447.216,452.209,457.203,460.184,462.471,465.772,472.257,474.543,476.83,480.652,486.433,491.947,494.609,497.59,502.584,504.871,508.172,515.287,517.574" y="146.34000000000003" svg_rhmargin="519.86" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Lamers, C.H.; Sleijfer, S.; van Steenbergen, S.; van Elzakker, P.; van Krimpen, B.; Groot, C.; Vulto, A.;</text>
  <text x="98.05,103.638,108.019,113.34200000000001,115.793,121.381,125.954,131.039,136.124,140.504,143.449,145.73600000000002,148.187,156.839,159.125,161.412,163.972,171.161,176.155,180.032,183.014,187.395,191.007,198.635,201.296,203.436,208.521,210.808,213.259,218.847,221.133,223.42000000000002,225.971,233.05,237.431,242.488,246.869,249.851,253.729,256.016,258.466,264.575,266.862,269.149,271.709,276.09,279.072,281.522,286.095,288.757,291.044,294.445,299.247,302.695,307.076,311.648,314.63,322.706,327.086,332.409,335.391,337.842,342.835,345.881,348.332,356.408,360.788,363.77,368.343,372.221,375.202,379.775,382.757,385.418,389.479,391.93,395.387,399.768,405.09,409.663,412.324,414.776,418.836,423.217,425.879,428.54,430.991,435.052,439.625,443.073,447.133,449.795,455.117,460.111,468.187,472.76,475.211,482.838,485.5,488.481,493.804,496.255,502.739,509.855,512.937" y="159.25099999999998" svg_rhmargin="519.037" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">den Bakker, M.; Oosterwijk, E.; Debets, R.; et al. Treatment of metastatic renal cell carcinoma with CAIX</text>
  <text svg_rhmargin="435.765" x="98.05,104.534,111.65,117.759,120.805,125.185,130.508,135.593,138.255,143.577,147.958,152.339,155.787,160.168,165.756,168.527,174.13299999999998,176.904,180.965,185.346,188.007,190.669,194.547,196.834,200.674,207.159,209.82,212.481,217.804,220.466,224.526,229.099,231.76,234.532,238.912,244.08,248.653,251.314,256.829,261.402,264.383,267.045,272.038,277.361,280.141,284.714,290.037,295.625,298.396,306.472,311.045,316.368,320.941,326.026,330.406,338.482,342.863,348.186,351.168,353.938,358.932,361.978,364.749,369.742,375.065,378.11,381.092,385.665,389.113,394.198,398.579,401.56100000000004,404.331,407.313,412.306,417.026,419.687,423.748,426.409,429.391,433.479,435.76599999999996" y="172.163" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">CAR-engineered T cells: Clinical evaluation and management of on-target toxicity. </text>
  <text svg_rhmargin="480.93" x="440.14,448.774,452.834,455.377,457.664,462.035,467.623,472.196,475.753,478.644,480.931" y="172.163" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Mol. Ther. </text>
  <text x="485.305,489.788,494.271,498.755" y="172.163" svg_rhmargin="503.238" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2013</text>
  <text svg_rhmargin="505.524" x="503.238,505.525" y="172.163" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="508.429,513.002" y="172.163" svg_rhmargin="517.575" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">21</text>
  <text x="517.575" y="172.163" svg_rhmargin="519.861" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="98.05,102.533,107.016,111.5,115.983,120.466,124.949,129.432,131.67399999999998,134.454,137.439,143.797,147.177,152.073,155.874,159.676,165.666,169.961,172.946,175.932,178.174,181.16,186.575,191.982,196.94,205.423,209.718,215.196" y="185.07399999999996" svg_rhmargin="218.182" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">904–912. [CrossRef] [PubMed]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="197.986" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">34. </text>
  <text x="98.05,106.373,110.753,116.076,121.161,123.44800000000001,126.146,129.191,131.478,133.76500000000001,136.691,142.279,146.852,149.513,151.8,154.497,158.869,161.156,163.443,166.369,173.557,176.219,181.541,183.828,186.526,192.114,194.4,196.687,199.622,205.211,209.783,212.436,214.723,217.429,222.533,224.819,227.106,230.032,233.078,235.739,240.312,245.635,250.72,253.007,255.704,261.804,264.091,266.378,269.304,274.892,280.407,285.4,287.68699999999995,290.394,296.878,299.165,301.452,304.378,311.987,317.502,322.075,327.397,332.483,334.77,337.467,343.567,345.854,348.14099999999996,351.067,359.764,365.279,367.566,370.264,375.065,377.351,379.638,382.565,387.366,392.689,397.262,402.255,404.542,407.249,414.328,416.614,418.90099999999995,421.827,428.906,433.287,438.61,443.695,445.98199999999997,448.679,455.163,457.45,459.73699999999997,462.663,467.044,470.026,472.723,477.296,479.957,482.24399999999997,486.405,493.52099999999996,496.219,501.541,506.535,511.702,516.083" y="197.986" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Weng, J.; Lai, P.; Qin, L.; Lai, Y.; Jiang, Z.; Luo, C.; Huang, X.; Wu, S.; Shao, D.; Deng, C.; et al. A novel</text>
  <text x="98.05,102.936,107.145,112.259,116.468,119.939,124.332,127.197,129.754,134.552,139.666,141.695,146.089,150.482,154.876,159.27,163.663,169.05,173.44400000000002,175.473,181.703,188.539,194.409,196.439,201.825,203.855,207.757,211.966,214.523,217.08,220.806,222.835,225.392,230.506,235.875,241.174,245.075,249.284,251.314,254.618,258.827,266.586,269.143,272.869,276.595,279.152,283.949,289.063,291.093,293.65,298.76399999999995,300.794,305.003,309.537,312.402,315.873,320.266,328.025,332.234,337.603,342.902,345.459,348.016,352.409,355.88,360.766,362.796,366.108,370.317,372.874,377.268,382.549,386.275,390.484,392.514,397.311,400.23699999999997,402.267,406.661,410.562,415.861,418.725,422.934,424.964,427.521,432.407,440.166,445.447,450.561,455.359,460.218,462.775,467.168,470.894,473.759,476.316,480.217,482.247,484.804,489.013,494.312,499.197,503.406,511.165,513.722,518.116" y="210.89800000000002" svg_rhmargin="520.313" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia.</text>
  <text svg_rhmargin="165.747" x="98.05,101.036,103.278,105.519,112.495,115.983,122.959,126.94,129.926,133.907,136.399,138.641,141.42,148.396,153.382,157.031,161.012,163.505,165.74699999999999" y="223.80899999999997" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">J. Hematol. Oncol. </text>
  <text x="168.525,173.008,177.491,181.975" y="223.80899999999997" svg_rhmargin="186.458" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2018</text>
  <text svg_rhmargin="188.7" x="186.458,188.7" y="223.80899999999997" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="190.941,195.424" y="223.80899999999997" svg_rhmargin="199.907" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="199.908,202.14999999999998,204.391,208.874,213.358,215.6,218.379,221.365,227.722,231.102,235.998,239.8,243.601,249.591,253.886,256.872,259.858,262.099,265.085,270.501,275.907,280.866,289.348,293.643,299.121" y="223.80899999999997" svg_rhmargin="302.107" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 25. [CrossRef] [PubMed]</text>
  <text x="76.535,81.018,85.501,87.74300000000001,98.05,104.83,109.273,112.623,118.052,123.223,127.479,130.323,132.54500000000002,134.792,140.728,142.949,145.17100000000002,147.428,155.86,161.218,163.44,165.697,172.574,174.796,177.018,179.265,185.565,190.737,194.993,198.503,201.089,205.531,210.703,212.925,215.172,219.837,222.059,224.281,226.537,231.478,235.921,241.092,246.032,248.25400000000002,250.502,258.908,261.129,263.351,265.608,273.001,277.443,282.615,287.058,292.434,294.656,296.903,302.332,304.554,311.467,313.688,315.90999999999997,318.167,323.107,325.684,330.855,336.027,340.283,344.228,346.45,348.707,355.691,357.912,360.13399999999996,362.382,367.047,374.893,377.479,380.375,385.547,389.803,393.313,397.081,399.303,401.55,408.943,411.164,413.38599999999997,415.643,418.602,422.858,428.03,431.797,436.053,441.225,443.447,445.694,454.1,456.322,462.622,464.843,467.065,469.321,475.257,477.843,483.272,488.701,492.957,495.543,498.129,500.351,502.598,507.263,509.485,515.421,517.642" y="236.721" svg_rhmargin="519.863" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">35. Gardner, R.; Wu, D.; Cherian, S.; Fang, M.; Hanaﬁ, L.A.; Finney, O.; Smithers, H.; Jensen, M.C.; Riddell, S.R.;</text>
  <text x="98.05,106.702,111.275,113.936,118.93,124.253,128.633,132.721,135.008,138.813,145.891,148.178,155.156,157.442,159.729,164.32,168.701,171.683,175.487,180.06,182.721,185.008,192.471,199.586,203.647,208.768,214.283,216.944,220.822,223.484,226.465,229.127,234.12,239.443,243.248,248.241,251.287,255.091,259.664,263.469,269.953,277.032,281.605,286.178,289.223,294.546,298.927,304.012,308.585,311.566,314.228,319.395,323.77599999999995,327.58,335.656,340.741,345.122,347.783,352.777,355.438,361.026,364.831,370.328,375.65,380.031,385.354,390.348,393.329,398.414,403.911,408.29200000000003,412.096,416.669,419.33,421.992,426.985,434.613,438.491,442.295,444.957,453.032,461.108,466.623,471.946,476.327,480.131,484.512,488.39,492.45,497.023,502.52,506.90099999999995,510.705,515.699" y="249.63199999999995" svg_rhmargin="518.745" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Maloney, D.G.; et al. Acquisition of a CD19-negative myeloid phenotype allows immune escape of</text>
  <text svg_rhmargin="318.848" x="98.05,106.532,112.011,117.489,120.475,123.855,128.15,132.633,136.175,139.717,144.2,149.419,154.404,158.699,164.17700000000002,166.419,171.897,174.883,181.859,187.337,192.815,195.057,198.043,201.424,206.319,214.236,216.478,222.835,229.775,234.259,238.742,240.983,247.341,254.316,260.306,263.292,268.78799999999995,271.03,275.011,279.306,281.915,284.524,286.766,289.689,294.907,299.202,302.744,307.227,312.616,316.606,318.848" y="262.544" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">MLL-rearranged B-ALL from CD19 CAR-T cell therapy. </text>
  <text svg_rhmargin="342.041" x="321.625,327.103,329.596,333.577,337.558,342.041" y="262.544" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Blood </text>
  <text x="344.283,348.766,353.249,357.733" y="262.544" svg_rhmargin="362.216" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2016</text>
  <text svg_rhmargin="364.458" x="362.216,364.458" y="262.544" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="366.699,371.182,375.665" y="262.544" svg_rhmargin="380.148" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">127</text>
  <text x="380.148,382.39000000000004,384.631,389.114,393.598,398.081,402.564,407.047,411.531,416.014,420.497,424.98,427.22200000000004,430.001,432.987,439.344,442.725,447.62,451.422,455.224,461.213,465.508,468.494,471.48,473.721,476.707,482.123,487.53,492.488,500.97,505.265,510.744" y="262.544" svg_rhmargin="513.73" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 2406–2410. [CrossRef] [PubMed]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="275.456" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">36. </text>
  <text x="98.05,103.959,109.115,114.457,116.672,118.912,123.829,126.044,134.424,136.639,138.854,141.095,149.502,154.844,157.059,159.309,165.217,167.432,169.647,171.888,176.495,180.924,186.08,188.29500000000002,190.536,195.444,197.658,201.858,204.072,206.287,208.528,215.385,220.727,222.942,225.183,230.099,232.314,237.231,239.445,241.66,243.901,249.314,251.892,257.234,259.44899999999996,261.69,267.599,269.813,272.02799999999996,274.269,281.232,286.574,288.789,291.03,296.948,299.163,307.543,309.758,311.97299999999996,314.223,319.635,322.213,327.555,329.77,332.011,336.662,338.877,341.092,343.333,348.683,354.025,356.23999999999995,358.481,364.762,366.977,371.078,373.293,375.508,377.749,380.699,383.277,387.706,392.862,397.788,400.003,402.243,405.193,407.408,409.623,411.873,419.899,424.328,429.484,434.41,436.625,438.875,441.825,444.039,448.229,450.444,452.659,454.9,459.144,462.032,464.273,468.702,471.28,473.49499999999995,476.276,483.169,488.324,491.212,493.79,496.74,503.021,509.878,514.307" y="275.456" svg_rhmargin="518.736" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Zhu, Y.M.; Wu, Z.; Tan, Y.P.; Du, Y.Y.; Liu, Z.; Ou, R.M.; Liu, S.; Pu, C.F.; Jiang, J.; Wang, J.P.; et al. Anti-CD19</text>
  <text x="98.05,102.067,107.332,109.965,117.954,122.287,125.861,128.493,132.51,134.736,139.26,144.525,147.474,150.107,155.137,159.471,164.736,166.962,170.372,174.706,178.723,183.057,188.494,191.443,196.383,199.95700000000002,202.182,207.23,210.243,214.26,218.594,221.226,223.859,226.085,229.034,234.299,238.633,242.206,246.73,252.167,257.197,259.423,262.436,267.375,270.949,273.175,277.698,283.226,288.681,291.314,294.26300000000003,296.489,301.953,307.219,309.852,312.484,317.008,322.536,326.869,329.502,334.939,340.205,342.837,347.361,349.577,353.594,358.86,362.28,367.219,375.208,380.148,383.984,388.923,396.912,401.245,404.258,409.686,414.626,418.462,421.095,424.044,426.677,431.788,436.122,438.348,442.871,446.888,452.343,455.293,459.627,461.852,464.485,469.515,477.503,482.941,488.206,493.146,498.149,500.782,505.305,509.141,512.09,514.723" y="288.367" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">chimeric antigen receptor T-cell therapy for adult Philadelphia chromosome-positive acute lymphoblastic</text>
  <text svg_rhmargin="208.248" x="98.05,100.659,104.954,110.361,115.346,119.641,127.558,130.168,134.651,136.893,139.672,144.361,151.839,156.734,158.977,162.958,167.441,171.243,175.53799999999998,177.779,181.16,185.455,190.843,195.739,199.281,202.204,206.006,208.248" y="301.279" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">leukemia: Two case reports. </text>
  <text svg_rhmargin="244.569" x="211.026,219.49,222.978,227.461,229.954,233.603,236.096,241.081,244.569" y="301.279" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Medicine </text>
  <text x="246.81,251.293,255.776,260.26" y="301.279" svg_rhmargin="264.743" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2016</text>
  <text svg_rhmargin="266.985" x="264.743,266.985" y="301.279" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="269.226,273.709" y="301.279" svg_rhmargin="278.192" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">95</text>
  <text x="278.192,280.434,282.675,286.97,291.453,295.937,300.42,304.903,307.14500000000004,309.924,312.91,319.267,322.647,327.543,331.345,335.147,341.136,345.431,348.417" y="301.279" svg_rhmargin="351.403" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, e5676. [CrossRef]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="314.19" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">37. </text>
  <text x="98.05,106.011,110.405,115.519,120.404,122.601,124.578,130.808,133.005,141.318,143.514,145.711,147.776,156.115,161.414,163.611,165.587,171.448,173.645,180.552,182.749,184.946,187.01,194.971,199.365,204.479,209.365,211.562,213.538,218.398,220.594,222.791,224.856,231.561,236.859,241.657,243.854,245.831,250.699,252.896,258.265,260.461,262.658,264.723,271.524,275.918,278.475,280.672,282.64,289.951,292.148,298.017,300.214,302.411,304.476,312.437,316.831,321.945,326.83,329.027,331.004,336.865,339.062,346.373,348.57,350.767,352.831,358.2,360.757,362.954,364.931,370.792,372.989,375.186,377.251,383.112,388.226,392.619,397.733,402.619,404.81600000000003,406.793,411.652,413.849,416.775,418.972,421.169,423.233,429.094,434.208,438.602,443.716,448.602,450.799,452.775,460.737,462.933,467.801,469.998,472.195,474.26,480.49,485.604,489.813,494.927,497.124,499.101,507.414,509.61,515.471,517.668" y="314.19" svg_rhmargin="519.865" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Wang, C.M.; Wu, Z.Q.; Wang, Y.; Guo, Y.L.; Dai, H.R.; Wang, X.H.; Li, X.; Zhang, Y.J.; Zhang, W.Y.; Chen, M.X.;</text>
  <text x="98.05,102.272,105.14500000000001,107.375,111.782,114.347,116.55099999999999,119.327,126.184,131.499,134.372,139.185,141.75,146.562,151.463,156.275,161.59,165.327,167.548,172.951,175.181,181.43,185.652,188.217,190.782,194.519,196.749,202.134,206.682,211.979,215.293,219.515,223.252,226.99,229.554,234.684,239.585,241.815,248.064,254.886,259.293,263.7,265.93,272.179,277.308,279.873,287.656,291.878,295.359,297.924,301.837,304.068,310.925,316.055,318.928,321.493,326.393,330.615,335.745,337.966,343.854,348.076,351.989,356.211,361.508,364.382,369.194,372.676,376.413,378.643,381.578,386.39,389.872,392.102,397.989,402.211,404.776,409.183,414.48,418.217,422.439,427.824,430.055,434.867,438.34900000000005,440.57,446.457,450.679,453.614,457.096,461.503,465.416,468.29,473.102,476.584,481.485,483.714,491.047,495.86,501.245,506.146,511.046,513.611" y="327.102" svg_rhmargin="518.741" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">et al. Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin</text>
  <text svg_rhmargin="263.194" x="98.05,103.035,108.021,115.938,121.327,126.545,131.441,139.358,143.841,146.083,148.863,155.838,161.05599999999998,163.298,170.346,175.735,180.03,185.248,188.234,193.713,198.196,203.154,207.449,210.05800000000002,212.3,217.716,222.934,227.417,231.219,235.51399999999998,237.755,240.777,243.019,247.708,251.25,253.859,258.342,260.952,263.194" y="340.014" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Lymphoma: An Open-Label Phase I Trial. </text>
  <text svg_rhmargin="329.956" x="265.971,271.952,274.444,276.937,281.922,284.16400000000004,286.943,292.924,296.905,301.89,305.54,309.028,312.516,314.757,320.738,324.226,327.714,329.956" y="340.014" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Clin. Cancer Res. </text>
  <text x="332.734,337.217,341.7,346.184" y="340.014" svg_rhmargin="350.667" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2017</text>
  <text svg_rhmargin="352.909" x="350.667,352.909" y="340.014" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="355.15,359.633" y="340.014" svg_rhmargin="364.116" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">23</text>
  <text x="364.116,366.358,368.599,373.082,377.566,382.049,386.532,391.015,395.499,399.982,404.465,408.948,411.19,413.969,416.955,423.312,426.693,431.588,435.39,439.192,445.181,449.476,452.462" y="340.014" svg_rhmargin="455.448" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 1156–1166. [CrossRef]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="352.925" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">38. </text>
  <text x="98.05,104.509,109.064,111.715,114.366,118.921,124.223,128.778,134.08,136.358,138.589,145.048,147.325,149.60299999999998,151.835,157.401,161.956,167.258,169.909,174.272,181.87,184.521,188.566,193.121,195.399,197.63,204.681,206.958,209.236,211.477,217.043,219.694,223.757,226.035,228.266,233.833,236.111,238.342,244.801,251.888,257.973,260.206,265.298,268.332,274.79,279.154,281.805,284.456,286.688,292.272,297.574,301.938,305.536,310.091,315.566,320.631,322.909,325.687,331.19,335.553,341.119,343.77,348.325,351.295,354.893,357.544,361.589,363.821,369.323,373.869,376.839,379.49,383.854,389.156,392.125,395.988,398.22,406.838,409.489,412.459,417.761,419.992,426.078,430.441,433.092,437.647,443.122,446.985,451.349,456.91499999999996,459.147,463.702,469.004,474.57,476.802,482.887,487.251,490.284,493.883,498.437,502.482,505.452,510.426,514.024" y="352.925" svg_rhmargin="519.089" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Callahan, C.; Baniewicz, D.; Ely, B. CAR T-Cell Therapy: Pediatric Patients With Relapsed and Refractory</text>
  <text svg_rhmargin="226.235" x="97.701,104.677,108.658,114.065,116.988,121.283,123.524,128.51,133.495,141.412,146.801,152.019,156.915,161.874,164.483,168.966,172.768,175.691,178.3,182.281,184.523,190.001,194.296,199.703,204.688,208.983,216.9,219.51,223.993,226.23499999999999" y="365.837" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Acute Lymphoblastic Leukemia. </text>
  <text svg_rhmargin="305.738" x="229.012,234.993,237.485,239.978,244.963,247.20499999999998,249.984,252.97,255.212,257.453,264.429,269.415,273.064,277.045,279.538,281.78000000000003,284.559,291.535,296.52,300.008,303.496,305.738" y="365.837" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Clin. J. Oncol. Nurs. </text>
  <text x="308.516,312.999,317.482,321.966" y="365.837" svg_rhmargin="326.449" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2017</text>
  <text svg_rhmargin="328.69" x="326.448,328.69" y="365.837" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="330.931,335.414" y="365.837" svg_rhmargin="339.897" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">21</text>
  <text x="339.898,342.14000000000004,344.381,348.864,353.348,357.831,362.314,366.797,369.03900000000004,371.818,374.804,381.161,384.542,389.437,393.239,397.041,403.031,407.325,410.311" y="365.837" svg_rhmargin="413.297" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 22–28. [CrossRef]</text>
  <text x="76.535,81.018,85.501,87.74300000000001,98.054,102.744,108.151,111.692,114.615,117.225,121.519,123.76100000000001,125.985,132.342,134.583,137.569,139.811,142.053,144.285,151.745,156.228,161.447,165.93,171.355,173.59699999999998,175.829,181.307,183.549,190.525,192.766,195.00799999999998,197.241,202.719,207.014,210.394,215.38,219.675,222.553,224.795,227.027,233.384,235.626,237.868,240.1,246.942,251.837,256.733,259.342,263.637,267.627,269.869,272.092,276.925,279.167,286.143,288.384,290.62600000000003,292.858,299.216,304.434,308.729,312.271,314.88,319.363,324.582,326.824,329.056,333.763,336.005,338.247,340.479,347.939,353.346,358.824,363.119,367.1,371.395,376.381,378.623,380.855,389.337,391.579,393.821,396.053,400.76,405.656,413.573,421.491,425.785,429.327,437.244,441.539,446.525,450.82,453.698,455.94,458.163,465.103,467.345,469.58700000000005,471.828,480.31,484.605,487.214,492.28,494.889,497.499,500.108,504.403,506.64500000000004,508.868,515.378,517.619" y="378.748" svg_rhmargin="519.861" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">39. Turtle, C.J.; Hanaﬁ, L.A.; Berger, C.; Gooley, T.A.; Cherian, S.; Hudecek, M.; Sommermeyer, D.; Melville, K.;</text>
  <text x="98.05,103.466,107.761,112.979,118.458,122.752,125.631,127.873,130.114,135.592,137.834,140.076,142.317,147.796,153.202,158.681,161.29,165.773,169.315,172.238,177.134,179.37599999999998,181.617,186.45,188.691,197.174,199.415,201.65699999999998,203.898,208.193,211.116,213.367,217.85,220.459,222.701,225.481,231.838,238.778,243.261,247.744,249.986,256.343,263.319,269.308,272.294,277.78999999999996,280.032,284.013,288.308,290.917,293.527,297.329,299.57,304.466,307.452,309.693,315.171,319.466,324.891,330.109,334.404,339.882,342.124,348.482,355.422,359.905,365.338,367.58,373.937,380.877,385.36,390.793,393.036,397.017,401.912,409.83,415.219,420.114,423.916,426.525,429.448,432.057,436.953,442.171,444.413,447.022,452.24,454.482,458.966,464.444,469.851,472.46,475.383,477.625,483.103,485.354,489.335,493.63,496.239,498.84799999999996,501.09,508.066,513.544" y="391.66" svg_rhmargin="519.022" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Pender, B.; Budiarto, T.M.; et al. CD19 CAR-T cells of deﬁned CD4+:CD8+ composition in adult B cell ALL</text>
  <text svg_rhmargin="131.665" x="97.781,103.17,107.653,110.576,113.185,117.48,122.699,125.622,129.423,131.665" y="404.572" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">patients. </text>
  <text svg_rhmargin="194.519" x="134.444,137.43,139.672,141.913,147.894,150.386,152.879,157.864,160.106,162.885,165.871,170.857,175.34,178.828,182.316,185.301,187.794,192.277,194.51899999999998" y="404.572" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">J. Clin. Investig. </text>
  <text x="197.298,201.781,206.264,210.748" y="404.572" svg_rhmargin="215.231" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2016</text>
  <text svg_rhmargin="217.473" x="215.231,217.47299999999998" y="404.572" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="219.714,224.197,228.68" y="404.572" svg_rhmargin="233.163" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">126</text>
  <text x="233.163,235.405,237.646,242.129,246.613,251.096,255.579,260.062,264.545,269.029,273.512,277.995,280.237,283.016,286.002,292.359,295.74,300.635,304.437,308.239,314.228,318.523,321.509" y="404.572" svg_rhmargin="324.495" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 2123–2138. [CrossRef]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="417.483" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">40. </text>
  <text x="98.05,106.373,110.753,113.415,115.70200000000001,118.719,125.698,127.984,130.271,133.682,141.291,146.806,149.09300000000002,152.11,157.214,159.5,161.787,165.198,170.722,176.237,178.524,181.541,188.026,190.312,192.59900000000002,196.01,201.305,206.82,209.107,212.125,215.17,217.457,219.744,223.155,228.743,234.257,239.251,241.538,244.556,249.668,251.954,254.241,257.643,262.445,267.767,270.429,272.71599999999995,275.742,278.788,281.074,283.361,286.763,293.247,298.762,301.424,303.71099999999996,306.737,313.926,316.212,318.49899999999997,321.91,330.608,336.123,338.40999999999997,341.427,349.75,352.036,354.323,357.725,366.047,370.62,375.943,381.028,383.315,386.333,389.378,391.665,393.952,397.362,403.463,406.124,410.697,415.69,417.977,421.004,426.592,428.879,431.166,434.567,438.948,441.93,444.957,449.53,452.191,454.47799999999995,459.59,466.074,473.153,477.726,482.299,485.317,488.298,492.871,496.328,501.413,505.794,508.776,513.156" y="417.483" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Wei, G.; Hu, Y.; Pu, C.; Yu, J.; Luo, Y.; Shi, J.; Cui, Q.; Wu, W.; Wang, J.; Xiao, L.; et al. CD19 targeted</text>
  <text x="98.05,104.375,111.316,117.276,120.247,125.716,127.946,130.855,136.047,140.32,143.844,148.305,153.667,158.62800000000001,160.858,165.899,170.172,173.696,177.479,182.858,186.641,188.863,192.824,198.016,202.29,210.167,215.039,217.947,223.139,227.413,230.937,235.398,240.759,245.72,247.95,250.546,255.739,257.969,261.333,265.606,268.577,271.173,276.365,281.816,287.196,291.157,294.066,296.662,301.533,306.726,308.956,311.864,315.228,319.501,323.962,326.861,334.739,339.013,344.205,347.114,349.344,354.215,357.186,359.416,362.78,367.053,370.024,373.548,378.009,381.97,384.878,389.75,393.274,398.234,403.64,407.004,411.277,413.874,418.334,423.696,427.479,431.752,437.20300000000003,439.434,443.895,447.856,453.235,456.144,460.418,462.639,465.235,470.195,478.073,483.435,488.627,493.499,498.432,501.028,505.489,509.272,512.18,514.776" y="430.395" svg_rhmargin="518.737" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic</text>
  <text svg_rhmargin="273.505" x="98.05,100.659,104.954,110.361,115.346,119.641,127.558,130.168,134.651,136.893,139.672,145.662,149.956,153.758,159.165,161.774,164.697,168.499,170.741,175.636,178.62199999999999,180.864,185.347,187.589,191.57,196.053,199.855,204.149,207.135,211.116,216.012,221.23,224.153,227.534,232.429,235.039,237.648,241.943,247.42100000000002,249.663,253.465,256.388,261.794,267.273,271.263,273.505" y="443.306" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">leukemia: Results of a case-controlled study. </text>
  <text svg_rhmargin="330.87" x="276.282,282.756,287.741,292.726,294.968,297.748,304.723,308.211,315.187,319.168,322.154,326.135,328.628,330.87" y="443.306" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Ann. Hematol. </text>
  <text x="333.648,338.131,342.614,347.098" y="443.306" svg_rhmargin="351.581" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2018</text>
  <text svg_rhmargin="353.823" x="351.581,353.82300000000004" y="443.306" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="356.064,360.547" y="443.306" svg_rhmargin="365.03" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">97</text>
  <text x="365.03,367.272,369.513,373.996,378.48,382.963,387.446,391.929,396.412,400.896,403.13800000000003,405.917,408.903,415.26,418.64,423.536,427.338,431.139,437.129,441.424,444.41" y="443.306" svg_rhmargin="447.396" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 781–789. [CrossRef]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="456.218" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">41. </text>
  <text x="98.05,106.373,110.945,116.268,121.353,123.64,126.438,131.542,133.828,138.931,141.218,143.505,146.586,151.388,156.711,159.372,161.65900000000002,164.457,170.557,172.844,179.923,182.209,184.496,187.568,193.156,195.818,198.10500000000002,200.903,203.948,206.235,213.844,216.131,218.418,221.49,227.59,232.913,237.486,242.809,247.894,250.181,252.979,259.079,261.365,267.466,269.752,272.039,275.121,280.709,283.37,285.657,288.455,291.501,293.787,296.833,299.119,301.406,304.478,309.563,313.944,319.267,324.352,326.63899999999995,329.437,334.239,336.525,343.714,346.001,348.799,355.283,357.944,360.606,365.929,368.59,372.651,377.224,379.885,382.684,389.872,394.93,398.807,403.188,406.801,411.968,416.541,419.522,422.184,427.177,432.5,435.299,440.292,443.33799999999997,446.137,452.621,459.7,464.272,468.84499999999997,471.644,478.128,485.244,491.35400000000004,494.152,499.758,502.556,509.041,513.422,516.083" y="456.218" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Wang, Y.Y.; Shi, X.D.; Li, J.H.; Zhang, X.X.; Li, J.J.; Feng, S.Q. Clinical Observation of CD19 CAR T Cell</text>
  <text svg_rhmargin="376.589" x="97.773,103.379,108.702,113.083,116.696,121.268,126.765,131.85,134.53,137.191,142.514,145.203,151.687,157.01,159.662,162.324,167.912,171.369,175.749,181.072,183.752,189.861,194.242,196.904,201.476,206.973,210.851,215.232,217.911,223.499,226.188,231.282,236.367,244.443,249.94,255.262,260.256,264.317,269.402,272.383,275.045,279.106,281.785,287.373,291.754,297.269,302.354,306.735,314.81,317.472,322.045,327.587,332.681,337.766,345.842,351.338,356.661,361.655,369.73,374.303,376.59" y="469.13" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Therapy in Children Relapse B Lymphocytic Leukemia/Lymphoma. </text>
  <text svg_rhmargin="481.313" x="380.692,383.738,386.025,388.704,391.749,396.834,401.919,404.20599999999996,408.312,416.946,421.006,426.091,430.664,432.95099999999996,437.048,445.682,449.239,453.812,456.099,460.205,467.32,472.405,474.948,479.027,481.31399999999996" y="469.13" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">J. Inn. Mong. Med. Univ. </text>
  <text x="485.417,489.9,494.383,498.867" y="469.13" svg_rhmargin="503.35" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2017</text>
  <text svg_rhmargin="505.636" x="503.35,505.637" y="469.13" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="508.429,513.002" y="469.13" svg_rhmargin="517.575" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">39</text>
  <text x="517.575" y="469.13" svg_rhmargin="519.861" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="97.602,102.085,106.568,111.052,115.535,120.018,124.501,128.984,131.226,134.006,136.991,143.349,146.729,151.625,155.426,159.228,165.218,169.513,172.498" y="482.041" svg_rhmargin="175.484" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">112–116. [CrossRef]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="494.953" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">42. </text>
  <text x="98.05,102.966,106.458,110.374,112.58399999999999,114.83,119.586,121.797,124.741,126.951,129.161,131.407,136.048,141.193,145.614,150.75,152.96,155.206,162.553,164.763,172.11,174.32,176.53,178.776,185.725,189.049,193.284,198.429,201.311,205.732,209.48,211.69,213.936,219.842,222.052,224.996,227.206,229.416,231.653,236.295,239.177,243.412,246.294,248.866,253.101,256.434,259.378,264.02,266.902,271.137,276.132,280.366,285.512,289.26,294.087,299.233,301.443,303.689,312.052,314.262,316.472,318.709,323.802,329.133,333.553,338.698,340.90799999999996,343.145,349.414,351.624,359.987,362.197,364.407,366.653,372.559,376.979,384.786,389.206,394.122,397.614,400.187,403.935,409.081,414.226,418.646,420.856,423.093,427.735,429.945,432.155,434.401,442.419,447.247,449.819,452.701,456.936,460.428,464.177,466.387,468.624,472.806,475.016,477.226,479.472,487.835,492.255,495.748,498.63,501.202,506.348,508.558,510.804,515.445,517.655" y="494.953" svg_rhmargin="519.865" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Fry, T.J.; Shah, N.N.; Orentas, R.J.; Stetler-Stevenson, M.; Yuan, C.M.; Ramakrishna, S.; Wolters, P.; Martin, S.;</text>
  <text x="98.05,104.9,109.139,111.714,116.608,119.945,124.777,129.609,134.529,136.742,138.981,145.255,147.468,149.68099999999998,151.919,156.999,161.424,164.309,168.548,172.3,174.513,176.752,182.159,184.371,186.584,188.832,193.071,195.956,198.195,202.62,205.195,207.408,210.186,216.461,223.311,227.736,232.161,235.107,237.993,242.417,245.754,250.674,254.913,257.798,262.038,267.445,269.684,275.958,282.844,288.756,290.994,296.41900000000004,298.667,302.596,306.835,309.411,311.986,315.738,317.977,320.553,325.703,331.111,336.447,340.376,344.61499999999995,346.854,350.191,354.43,362.244,364.82,368.572,372.324,374.9,379.732,384.88300000000004,387.121,389.697,394.848,397.086,402.493,405.44,412.326,417.733,423.14,425.388,428.273,433.424,437.848,440.733,442.973,445.548,449.3,451.539,456.69,461.115,463.69,468.69,472.929,475.177,480.009,483.505,485.744,489.08,493.319,497.072,499.647,503.399,506.284,510.709,515.86" y="507.864" svg_rhmargin="518.745" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Delbrook, C.; Yates, B.; et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant</text>
  <text svg_rhmargin="255.976" x="98.05,100.973,105.868,108.11,114.467,121.407,125.891,130.374,133.36,136.283,140.766,144.146,149.132,153.426,156.35,160.644,166.122,168.365,174.722,181.698,187.687,189.929,192.538,200.455,208.373,213.779,218.998,223.893,226.817,232.035,236.33,239.872,244.355,249.744,253.734,255.976" y="520.7760000000001" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">to CD19-targeted CAR immunotherapy. </text>
  <text svg_rhmargin="296.394" x="258.753,265.729,269.71,272.696,274.93800000000005,277.717,286.181,289.669,294.152,296.394" y="520.7760000000001" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Nat. Med. </text>
  <text x="299.173,303.656,308.139,312.623" y="520.7760000000001" svg_rhmargin="317.106" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2018</text>
  <text svg_rhmargin="319.348" x="317.106,319.348" y="520.7760000000001" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="321.589,326.072" y="520.7760000000001" svg_rhmargin="330.555" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">24</text>
  <text x="330.556,332.798,335.039,339.522,344.006,348.489,352.972,357.455,359.697,362.476,365.462,371.819,375.2,380.095,383.897,387.699,393.688,397.983,400.969,403.955,406.197,409.182,414.598,420.005,424.963,433.445,437.74,443.219" y="520.7760000000001" svg_rhmargin="446.205" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 20–28. [CrossRef] [PubMed]</text>
  <text svg_rhmargin="87.743" x="76.535,81.018,85.501,87.74300000000001" y="533.688" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">43. </text>
  <text x="98.05,104.69,109.683,113.744,119.067,123.448,128.771,134.359,138.739,142.352,145.397,149.778,152.723,155.01000000000002,157.826,160.872,163.158,170.759,173.045,175.332,178.423,185.501,191.016,196.604,199.266,203.647,207.735,210.02200000000002,212.829,221.481,223.767,229.355,231.642,233.929,237.019,243.659,248.232,252.11,255.988,258.649,266.725,269.012,271.819,276.62,278.907,286.516,288.803,291.09,294.18,298.982,303.975,312.051,316.432,320.044,325.212,327.873,330.534,333.196,337.577,339.864,342.671,348.78,351.067,355.438,357.725,360.012,363.102,369.587,374.16,377.772,383.269,387.65,392.972,395.954,400.335,403.28,405.56699999999995,408.383,414.492,416.779,423.967,426.254,428.541,431.631,436.433,439.414,443.795,446.777,449.438,453.819,457.267,460.312,465.114,468.095,472.476,477.643,482.024,487.347,491.225,496.218,501.541,503.828,506.635,515.287,517.574" y="533.688" svg_rhmargin="519.86" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Kochenderfer, J.N.; Dudley, M.E.; Kassim, S.H.; Somerville, R.P.; Carpenter, R.O.; Stetler-Stevenson, M.;</text>
  <text x="97.755,103.032,107.605,112.928,118.013,120.30000000000001,123.317,126.363,128.649,135.134,137.42,139.707,143.118,148.642,153.965,158.538,163.86,166.14700000000002,169.174,176.152,178.439,185.627,187.914,190.201,193.611,201.221,206.736,211.821,217.143,221.524,225.402,227.689,230.706,239.358,241.645,246.446,248.733,251.02,254.44,259.241,264.564,268.945,272.557,276.17,280.258,282.54499999999996,285.563,291.672,293.958,302.61,304.897,307.18399999999997,310.594,314.975,317.95700000000005,320.984,325.557,328.218,330.505,335.626,342.111,347.433,351.814,359.89,364.883,367.865,373.188,377.569,381.181,385.754,391.251,396.336,399.381,402.829,407.21,410.255,413.868,418.441,422.502,425.483,430.477,434.089,439.174,442.201,447.789,450.451,453.332,456.377,461.892,465.77,470.15099999999995,473.169,475.83,480.403,483.851,488.936,493.317,496.344,501.932,504.978,509.038,513.419,516.081" y="546.5989999999999" svg_rhmargin="518.742" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Yang, J.C.; Phan, G.Q.; Hughes, M.S.; Sherry, R.M.; et al. Chemotherapy-refractory diffuse large B-cell</text>
  <text x="98.05,100.623,105.538,113.345,118.658,123.803,128.631,136.437,140.858,143.085,147.506,152.651,158.053,160.281,162.854,167.999,173.401,178.228,180.801,185.035,190.181,193.06300000000002,195.291,200.693,203.637,207.562,211.797,214.369,216.942,219.17,226.976,231.397,233.97,236.542,241.458,246.603,251.024,256.169,260.094,262.667,266.902,270.651,272.878,276.804,281.224,286.36899999999997,288.606,293.495,297.73,299.958,304.193,306.969,309.922,314.156,318.082,320.964,323.536,328.532,332.766,335.339,340.255,342.482,345.365,348.689,352.924,357.344,360.226,364.461,369.863,372.099,379.473,382.045,384.927,390.072,392.301,396.721,402.052,404.934,409.761,412.334,417.161,422.077,426.904,432.235,435.98400000000004,438.211,443.63100000000003,445.859,449.784,454.019,456.592,459.164,462.913,465.141,469.376,473.937,479.251,482.584,486.819,490.567,494.316,496.888,502.034,506.95,509.177,513.598" y="559.511" svg_rhmargin="518.743" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an</text>
  <text svg_rhmargin="243.423" x="98.05,102.533,107.752,110.675,113.284,116.27,122.627,129.567,134.05,138.53300000000002,140.775,144.756,149.974,152.584,160.501,164.796,168.338,170.947,174.928,177.17,181.653,186.871,189.794,192.403,197.389,201.684,206.902,209.144,212.524,216.819,220.8,225.095,230.484,233.407,238.302,241.181,243.423" y="572.422" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">anti-CD19 chimeric antigen receptor. </text>
  <text svg_rhmargin="298.968" x="246.2,249.186,251.428,253.669,259.65,262.142,264.635,269.62,271.862,274.641,281.617,286.603,290.252,294.233,296.726,298.968" y="572.422" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">J. Clin. Oncol. </text>
  <text x="301.746,306.229,310.712,315.196" y="572.422" svg_rhmargin="319.679" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2015</text>
  <text svg_rhmargin="321.921" x="319.679,321.921" y="572.422" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="324.162,328.645" y="572.422" svg_rhmargin="333.128" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">33</text>
  <text x="333.128,335.37,337.611,342.094,346.578,351.061,355.544,360.027,364.51,368.994,371.23600000000005,374.015,377.001,383.358,386.738,391.634,395.436,399.237,405.227,409.522,412.508,415.49399999999997,417.735,420.721,426.137,431.543,436.502,444.984,449.279,454.757" y="572.422" svg_rhmargin="457.743" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 540–549. [CrossRef] [PubMed]</text>
  <text x="76.535,81.018,85.501,87.74300000000001,98.05,106.456,110.899,116.257,121.686,125.942,128.164,130.412,135.077,137.298,142.727,144.949,147.17100000000002,149.436,154.376,157.717,161.974,165.919,168.14100000000002,170.397,177.781,180.003,182.225,184.481,189.146,194.318,198.761,205.345,207.567,209.814,214.026,216.248,223.161,225.382,227.604,229.86,236.774,242.114,244.7,248.956,254.127,258.073,260.29499999999996,262.551,268.487,270.708,272.93,275.186,280.616,285.058,288.568,291.918,296.174,299.071,301.968,304.19,306.437,313.315,315.536,323.942,326.164,328.38599999999997,330.642,336.071,341.429,346.601,349.187,354.358,356.58,358.828,366.212,368.433,371.392,373.613,375.835,378.092,384.392,389.563,393.82,400.413,402.635,404.882,411.795,414.017,416.239,418.495,425.275,430.127,435.298,439.741,444.184,446.769,451.026,455.469,457.691,459.947,465.198,467.42,472.849,475.07,477.292,479.549,485.476,490.647,494.903,500.075,505.015,507.23699999999997,509.494,515.42,517.642" y="585.3340000000001" svg_rhmargin="519.863" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">44. Maude, S.L.; Frey, N.; Shaw, P.A.; Aplenc, R.; Barrett, D.M.; Bunin, N.J.; Chew, A.; Gonzalez, V.E.; Zheng, Z.;</text>
  <text svg_rhmargin="454.239" x="98.05,103.638,108.211,112.272,116.652,120.741,123.028,125.487,130.289,132.575,136.837,139.123,141.41,143.971,148.352,151.334,153.784,158.357,161.018,163.305,166.734,173.219,178.542,181.203,189.279,193.659,197.272,199.933,203.994,206.445,211.018,216.341,219.322,221.984,227.069,231.45,236.773,239.233,242.681,247.061,251.122,255.503,260.999,263.981,268.974,272.587,275.047,280.653,283.105,287.165,291.546,294.207,296.869,300.747,303.207,306.252,311.246,314.859,317.31,321.187,326.702,330.58,333.561,338.134,340.796,346.119,350.499,356.08700000000005,358.548,361.996,366.376,374.452,377.113,380.991,384.869,387.53,392.524,397.847,401.72499999999997,404.185,406.846,412.169,414.62,417.281,421.662,427.177,432.262,436.643,444.719,447.38,451.953,454.23999999999995" y="598.246" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Lacey, S.F.; et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. </text>
  <text x="457.666,464.781,467.068,469.528,475.116,480.201,484.774,487.316,489.60299999999995,493.023,496.069,498.356,500.806,509.44,512.998,517.571" y="598.246" svg_rhmargin="519.857" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">N. Engl. J. Med.</text>
  <text x="98.05,102.533,107.016,111.5" y="611.157" svg_rhmargin="115.983" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2014</text>
  <text svg_rhmargin="118.225" x="115.983,118.22500000000001" y="611.157" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="120.466,124.949,129.432" y="611.157" svg_rhmargin="133.915" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">371</text>
  <text x="133.916,136.158,138.399,142.882,147.366,151.849,156.332,160.815,165.298,169.782,174.265,178.748,180.98999999999998,183.769,186.755,193.112,196.493,201.388,205.19,208.992,214.981,219.276,222.262,225.248,227.489,230.475,235.891,241.298,246.256,254.738,259.033,264.512" y="611.157" svg_rhmargin="267.498" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 1507–1517. [CrossRef] [PubMed]</text>
  <text x="76.535,81.018,85.501,87.74300000000001,98.05,103.417,108.269,111.778,114.675,118.931,121.775,123.997,126.235,133.113,135.334,140.764,142.985,145.20700000000002,147.446,154.839,162.249,166.692,171.864,176.804,179.026,181.265,189.324,191.545,196.326,198.547,200.769,203.008,207.948,211.298,215.554,219.5,221.722,223.96,231.344,233.566,238.826,241.048,243.27,245.499,250.928,255.371,259.317,263.573,267.518,269.73999999999995,271.979,276.644,278.865,282.979,285.201,287.423,289.661,294.326,299.498,303.941,310.525,312.74699999999996,314.986,319.197,321.419,328.332,330.553,332.775,335.014,340.443,345.295,348.645,352.901,358.072,360.294,362.533,369.446,371.668,379.727,381.948,384.16999999999996,386.409,391.838,396.281,401.221,406.162,408.38399999999996,410.614,417.527,419.748,421.96999999999997,424.209,432.615,437.057,440.407,444.353,449.711,453.656,457.601,460.187,462.409,464.648,471.099,473.32,478.101,480.322,482.544,484.783,489.448,494.619,498.875,504.047,506.269,508.507,515.421,517.642" y="624.069" svg_rhmargin="519.863" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">45. Porter, D.L.; Hwang, W.T.; Frey, N.V.; Lacey, S.F.; Shaw, P.A.; Loren, A.W.; Bagg, A.; Marcucci, K.T.; Shen, A.;</text>
  <text x="98.05,105.028,110.022,115.345,119.917,124.49,127.152,131.533,136.105,138.392,140.678,146.129,148.416,150.703,153.016,157.397,160.379,162.665,167.237,169.899,172.186,175.112,181.596,186.919,189.58,197.656,202.037,205.65,208.311,212.372,214.658,219.231,224.554,227.535,230.197,235.282,239.662,244.985,247.281,250.729,255.11,259.17,263.551,269.048,272.029,277.023,280.636,282.922,288.528,290.824,294.884,299.265,301.927,304.588,308.466,310.752,316.249,320.63,324.242,328.12,330.781,334.659,337.641,339.927,344.5,349.823,355.411,357.706,360.368,365.69,371.279,376.793,380.854,385.235,387.521,391.399,396.914,400.792,403.773,408.346,411.008,416.33,420.711,426.29900000000004,428.586,432.043,436.423,444.499,447.161,451.038,454.916,457.578,462.571,467.894,471.772,474.058,476.72,482.043,484.329,487.786,492.167,494.828,499.401,504.898,508.775,513.156" y="636.981" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Gonzalez, V.; et al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed</text>
  <text svg_rhmargin="261.409" x="98.05,101.43,105.725,108.711,112.253,116.736,120.717,123.64,128.536,132.077,137.062,139.304,143.285,148.504,151.884,156.78,161.998,164.608,168.589,170.83,173.44,178.425,186.342,191.731,196.949,201.845,205.826,210.811,213.735,216.344,220.325,222.566,225.176,229.471,234.877,239.863,244.158,252.075,254.684,259.167,261.409" y="649.892" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">refractory chronic lymphocytic leukemia. </text>
  <text svg_rhmargin="326.951" x="264.186,269.171,272.821,275.313,277.555,280.334,284.818,288.306,292.287,297.272,300.76,303.253,305.495,308.274,316.738,320.226,324.709,326.951" y="649.892" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">Sci. Transl. Med. </text>
  <text x="329.73,334.213,338.696,343.18" y="649.892" svg_rhmargin="347.663" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2015</text>
  <text svg_rhmargin="349.904" x="347.662,349.904" y="649.892" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="352.146" y="649.892" svg_rhmargin="356.629" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">7</text>
  <text x="356.629,358.87100000000004,361.112,365.595,370.079,374.562,378.104,382.587,387.07,391.553,396.036,398.278,401.058,404.043,410.401,413.781,418.677,422.478,426.28,432.27,436.565,439.55,442.536,444.778,447.764,453.179,458.586,463.544,472.027,476.322,481.8" y="649.892" svg_rhmargin="484.786" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 303ra139. [CrossRef] [PubMed]</text>
  <text x="76.535,81.018,85.501,87.74300000000001,98.054,104.044,108.527,116.444,121.34,125.142,127.384,129.625,135.982,138.224,145.2,147.441,149.683,151.925,157.403,161.886,164.495,167.105,171.588,174.968,180.447,182.689,184.939,190.417,192.659,194.90099999999998,197.142,203.123,208.341,212.824,218.043,223.028,225.26999999999998,227.511,234.971,237.213,239.45499999999998,241.705,248.645,253.128,258.114,263.332,268.228,273.294,277.777,280.019,282.26,289.308,291.549,293.791,296.033,302.874,307.169,311.464,313.706,315.956,322.932,325.173,329.432,331.674,333.916,336.157,344.639,348.934,351.544,353.786,356.027,362.007,364.249,366.49100000000004,368.741,374.22,376.829,379.438,384.423,387.033,389.27500000000003,391.516,399.998,402.24,404.482,406.723,415.241,420.648,422.89000000000004,425.14,433.622,435.864,440.024,442.266,444.50800000000004,446.749,452.227,454.837,460.243,462.485,464.727,472.187,474.428,476.67,478.92,485.762,489.304,491.913,494.522,497.131,501.426,505.416,507.658,509.899,515.378,517.619" y="662.804" svg_rhmargin="519.861" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">46. Ramos, C.A.; Ballard, B.; Zhang, H.; Dakhova, O.; Gee, A.P.; Mei, Z.; Bilgi, M.; Wu, M.F.; Liu, H.; Grilley, B.;</text>
  <text x="98.05,102.431,105.413,109.034,113.607,116.268,118.555,125.469,131.953,134.615,137.276,142.599,145.26,149.321,153.894,156.555,160.177,164.75,170.073,175.661,179.273,181.935,190.01,198.086,203.601,208.924,213.917,216.579,221.572,226.657,229.319,233.379,237.952,240.613,244.235,247.692,252.073,255.942,261.438,266.432,271.755,275.633,280.013,283.89099999999996,287.513,292.086,295.131,298.113,302.494,306.107,309.728,316.212,323.291,327.864,332.437,335.482,339.36,344.857,349.237,353.298,355.96,361.493,365.554,369.175,373.236,378.559,381.22,389.296,393.676,397.289,399.95,404.01099999999997,407.633,412.206,417.529,420.51,423.162,428.247,432.628,437.95099999999996,441.573,445.03,449.41,453.471,457.852,463.349,466.33,471.324,474.772,477.817,481.265,485.646,491.234,493.895,497.352,501.733,505.794,508.775,513.156" y="675.715" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">et al. Clinical and immunological responses after CD30-speciﬁc chimeric antigen receptor-redirected</text>
  <text svg_rhmargin="151.293" x="98.05,100.659,105.645,113.562,118.951,124.169,129.065,133.046,138.031,140.954,145.249,149.051,151.29299999999998" y="688.627" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">lymphocytes. </text>
  <text svg_rhmargin="214.147" x="154.072,157.058,159.29999999999998,161.541,167.522,170.014,172.507,177.492,179.73399999999998,182.513,185.499,190.485,194.968,198.456,201.944,204.929,207.422,211.905,214.147" y="688.627" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">J. Clin. Investig. </text>
  <text x="216.925,221.408,225.891,230.375" y="688.627" svg_rhmargin="234.858" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">2017</text>
  <text svg_rhmargin="237.1" x="234.858,237.1" y="688.627" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="239.341,243.824,248.307" y="688.627" svg_rhmargin="252.79" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:8.97px;font-style:italic;font-weight:normal;">127</text>
  <text x="252.791,255.033,257.274,261.757,266.241,270.724,275.207,279.69,284.173,288.657,293.14,297.623,299.865,302.644,305.63,311.987,315.368,320.263,324.065,327.867,333.856,338.151,341.137,344.123,346.364,349.35,354.766,360.173,365.131,373.613,377.908,383.387" y="688.627" svg_rhmargin="386.373" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">, 3462–3471. [CrossRef] [PubMed]</text>
 </g>
</svg>
